Delta Dental of Michigan, Delta Dental of North Carolina and OraLiva Inc. Announce Multi-State Launch of AI-Powered Oral Cancer Test
Read More
Stay informed with the latest developments from OraLiva
OraLiva is pleased to announce a collaboration with Rovers Medical Devices, a global leader in medical sampling devices, to support
New collaboration covers non-invasive cytology and AI risk-stratification to dentists across Michigan, Ohio, Indiana, and North Carolina Durham, NC —
NEW YORK, Oct. 6, 2025 — OraLiva, Inc., an AI precision diagnostics company, today announced the close of a $2.0
OraLiva, Inc. is preparing to launch its first noninvasive, AI-powered oral cancer test following recent NIH funding support. The test
OraLiva, Inc. is on the cusp of launching an AI-powered cytology “lab-in-a-kit” platform aimed at transforming early oral cancer diagnosis.
OraLiva, Inc. has been awarded a prestigious Direct to Phase II SBIR grant from the National Institute of Dental and
